WO1997024116A3 - METHODS OF TREATMENT WITH COMPOUNDS HAVING RARα RECEPTOR SPECIFIC OR SELECTIVE ACTIVITY - Google Patents
METHODS OF TREATMENT WITH COMPOUNDS HAVING RARα RECEPTOR SPECIFIC OR SELECTIVE ACTIVITY Download PDFInfo
- Publication number
- WO1997024116A3 WO1997024116A3 PCT/US1996/020511 US9620511W WO9724116A3 WO 1997024116 A3 WO1997024116 A3 WO 1997024116A3 US 9620511 W US9620511 W US 9620511W WO 9724116 A3 WO9724116 A3 WO 9724116A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- treatment
- compounds
- methods
- receptor specific
- retinoids
- Prior art date
Links
- 102100023606 Retinoic acid receptor alpha Human genes 0.000 title abstract 2
- 230000000694 effects Effects 0.000 title abstract 2
- 108091008726 retinoic acid receptors α Proteins 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 title 1
- 206010000871 Acute monocytic leukaemia Diseases 0.000 abstract 1
- 208000035489 Monocytic Acute Leukemia Diseases 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 206010033128 Ovarian cancer Diseases 0.000 abstract 1
- 206010035226 Plasma cell myeloma Diseases 0.000 abstract 1
- 102100033909 Retinoic acid receptor beta Human genes 0.000 abstract 1
- -1 Retinoid compounds Chemical class 0.000 abstract 1
- 206010040880 Skin irritation Diseases 0.000 abstract 1
- 206010043275 Teratogenicity Diseases 0.000 abstract 1
- 208000019065 cervical carcinoma Diseases 0.000 abstract 1
- 201000003911 head and neck carcinoma Diseases 0.000 abstract 1
- 201000000050 myeloid neoplasm Diseases 0.000 abstract 1
- 102000005962 receptors Human genes 0.000 abstract 1
- 108020003175 receptors Proteins 0.000 abstract 1
- 108091008761 retinoic acid receptors β Proteins 0.000 abstract 1
- 231100000475 skin irritation Toxicity 0.000 abstract 1
- 230000036556 skin irritation Effects 0.000 abstract 1
- 231100000211 teratogenicity Toxicity 0.000 abstract 1
- 231100000419 toxicity Toxicity 0.000 abstract 1
- 230000001988 toxicity Effects 0.000 abstract 1
- 230000004580 weight loss Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/203—Retinoic acids ; Salts thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/06—Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N25/00—Investigating or analyzing materials by the use of thermal means
- G01N25/20—Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity
- G01N25/48—Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity on solution, sorption, or a chemical reaction not involving combustion or catalytic oxidation
- G01N25/4846—Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity on solution, sorption, or a chemical reaction not involving combustion or catalytic oxidation for a motionless, e.g. solid sample
- G01N25/4866—Investigating or analyzing materials by the use of thermal means by investigating the development of heat, i.e. calorimetry, e.g. by measuring specific heat, by measuring thermal conductivity on solution, sorption, or a chemical reaction not involving combustion or catalytic oxidation for a motionless, e.g. solid sample by using a differential method
Abstract
Priority Applications (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU13450/97A AU710483B2 (en) | 1995-12-29 | 1996-12-16 | Methods of treatment with compounds having raralpha receptor specific or selective activity |
KR1019980704939A KR19990076814A (en) | 1995-12-29 | 1996-12-16 | Therapeutic methods using compounds having specific or selective activity of RAR alpha receptors |
BR9612318-4A BR9612318A (en) | 1995-12-29 | 1996-12-16 | "methods of treatment with compounds having specific or selective activity on the raralpha receptor" |
HU0001643A HUP0001643A3 (en) | 1995-12-29 | 1996-12-16 | Use of chromane-, phenyl-, naphtyl- or pyridine carboxilic acid derivatives for preparing pharmaceutical compositions with antitumor activity |
EP96944978A EP0869782A2 (en) | 1995-12-29 | 1996-12-16 | METHODS OF TREATMENT WITH COMPOUNDS HAVING RAR $g(a)? RECEPTOR SPECIFIC OR SELECTIVE ACTIVITY |
JP09524502A JP2000502707A (en) | 1995-12-29 | 1996-12-16 | Methods of treatment with compounds having RARα receptor specific or selective activity |
IL12512196A IL125121A0 (en) | 1995-12-29 | 1996-12-16 | Methods of treatment with compounds having raralpha receptor specific or selective activity |
NZ326155A NZ326155A (en) | 1995-12-29 | 1996-12-16 | Use of compounds that bind selectively or specifically to RAR-alpha retinoid receptors for treating tumours |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/580,553 US5965606A (en) | 1995-12-29 | 1995-12-29 | Methods of treatment with compounds having RAR.sub.α receptor specific or selective activity |
US08/580,553 | 1995-12-29 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1997024116A2 WO1997024116A2 (en) | 1997-07-10 |
WO1997024116A3 true WO1997024116A3 (en) | 1997-11-13 |
Family
ID=24321568
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1996/020511 WO1997024116A2 (en) | 1995-12-29 | 1996-12-16 | METHODS OF TREATMENT WITH COMPOUNDS HAVING RARα RECEPTOR SPECIFIC OR SELECTIVE ACTIVITY |
Country Status (16)
Country | Link |
---|---|
US (4) | US5965606A (en) |
EP (1) | EP0869782A2 (en) |
JP (1) | JP2000502707A (en) |
KR (1) | KR19990076814A (en) |
CN (1) | CN1211180A (en) |
AU (1) | AU710483B2 (en) |
BR (1) | BR9612318A (en) |
CA (1) | CA2241758A1 (en) |
CZ (1) | CZ206998A3 (en) |
HU (1) | HUP0001643A3 (en) |
IL (1) | IL125121A0 (en) |
MX (1) | MX9805282A (en) |
NZ (1) | NZ326155A (en) |
PL (1) | PL327627A1 (en) |
RU (1) | RU2191009C2 (en) |
WO (1) | WO1997024116A2 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8198329B2 (en) | 2004-03-10 | 2012-06-12 | Research Foundation Itsuu Laboratory | Memory consolidation promoting agent and method of use |
Families Citing this family (76)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5977125A (en) | 1994-10-31 | 1999-11-02 | Eisai Co., Ltd. | Mono-or polyenic carboxylic acid derivatives |
JP3964478B2 (en) | 1995-06-30 | 2007-08-22 | エーザイ・アール・アンド・ディー・マネジメント株式会社 | Heterocycle-containing carboxylic acid derivative and pharmaceutical containing the same |
US5965606A (en) * | 1995-12-29 | 1999-10-12 | Allergan Sales, Inc. | Methods of treatment with compounds having RAR.sub.α receptor specific or selective activity |
US20040266715A1 (en) * | 1999-03-31 | 2004-12-30 | Wong Liang Fong | Neurite regeneration |
US20070213290A1 (en) * | 1996-10-17 | 2007-09-13 | Kingsman Alan J | Neurite regeneration |
GB9907461D0 (en) * | 1999-03-31 | 1999-05-26 | King S College London | Neurite regeneration |
CA2307613A1 (en) | 1997-10-22 | 1999-04-29 | Eisai Co., Ltd. | Retinoic acid agonist as a prophylactic and therapeutic agent for nephritis |
US6083973A (en) * | 1998-03-09 | 2000-07-04 | Syntex (U.S.A.) Inc. | Methods for inhibiting mucin secretion using RAR α selective antagonists |
FR2776511B1 (en) * | 1998-03-31 | 2001-05-11 | Galderma Rech Dermatologique | USE IN OR FOR THE PREPARATION OF A COMPOSITION OF AT LEAST ONE INHIBITOR OF RETINOIC ACID ACTIVITY |
US6197798B1 (en) | 1998-07-21 | 2001-03-06 | Novartis Ag | Amino-benzocycloalkane derivatives |
US6833373B1 (en) | 1998-12-23 | 2004-12-21 | G.D. Searle & Co. | Method of using an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia |
WO2001053260A1 (en) | 2000-01-18 | 2001-07-26 | Novartis Ag | Carboxamides useful as inhibitors of microsomal triglyceride transfer protein and of apolipoprotein b secretion |
EP1268835B1 (en) * | 2000-03-30 | 2008-01-16 | Oxford Biomedica (UK) Limited | Retinoic acid receptor beta-2 and gene therapy vectors for the treatment of neurological disorders |
TWI281911B (en) * | 2000-04-04 | 2007-06-01 | Allergan Inc | Treatment of tumors with RARalpha selective retinoid compounds in combination with other anti-tumor agents |
US6369261B1 (en) | 2000-08-29 | 2002-04-09 | Allergan Sales, Inc. | Compounds having activity as inhibitors of cytochrome P450RAI |
US6380256B1 (en) | 2000-08-29 | 2002-04-30 | Allergan Sales, Inc. | Compounds having activity as inhibitors of cytochrome P450RAI |
US6387951B1 (en) | 2000-08-29 | 2002-05-14 | Allergan Sales, Inc. | Compounds having activity as inhibitors of cytochrome P450RAI |
US6313107B1 (en) | 2000-08-29 | 2001-11-06 | Allergan Sales, Inc. | Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI |
US6252090B1 (en) | 2000-08-29 | 2001-06-26 | Allergan Sales, Inc. | Compounds having activity as inhibitors of cytochrome P450RAI |
US6369225B1 (en) | 2000-08-29 | 2002-04-09 | Allergan Sales, Inc. | Compounds having activity as inhibitors of cytochrome P450RAI |
ATE315558T1 (en) * | 2000-08-29 | 2006-02-15 | Allergan Inc | COMPOUNDS WITH CYTOCHROME P450RA1 INHIBITIVE ACTIVITY |
EP1935869A1 (en) * | 2000-10-02 | 2008-06-25 | F. Hoffmann-La Roche Ag | Retinoids for the treatment of emphysema |
EP1324970B1 (en) * | 2000-10-02 | 2008-11-05 | F. Hoffmann-La Roche Ag | Retinoids for the treatment of emphysema |
JP2002131257A (en) * | 2000-10-26 | 2002-05-09 | Nisshinbo Ind Inc | Method and apparatus for measuring thermal conductivity, and method for fabricating heat insulating material |
US6843595B2 (en) * | 2001-01-26 | 2005-01-18 | Waters Investment Limited | Differential scanning calorimeter accounting for heat leakage |
AU2002333655A1 (en) | 2001-09-25 | 2003-04-07 | Smithkline Beecham Corporation | Bicyclic heterocycles as rxr ligands |
US6740676B2 (en) | 2002-03-19 | 2004-05-25 | Allergan, Inc. | 4-[(8-ethynyl, 8-vinyl or 8-ethynyl-methyl)-6-chromanoyl]-benzoic and 2-[4-[(8-ethynyl, 8-vinyl or 8-ethynyl-methyl)-6-chromanoyl]-phenyl]-acetic acid, their esters and salts having cytochrome p450rai inhibitory activity |
DE10227182B4 (en) * | 2002-06-18 | 2013-01-31 | Mettler-Toledo Ag | Sample holder for differential thermal analysis |
US6620963B1 (en) | 2002-09-19 | 2003-09-16 | Allergan, Inc. | TRICYCLO[6.2.202,7]DODECA-2(7),3,5-TRIEN-4-CARBONYLAMINO-PHENYL AND TRICYCLO[6.2.202,7]DODECA-2(7),3,5-TRIEN-4-CARBONYLAMINO-HETEROARYL AND RELATED COMPOUNDS HAVING RARα RECEPTOR SELECTIVE BIOLOGICAL ACTIVITY |
EP1528392B1 (en) * | 2003-10-28 | 2007-08-29 | Mettler-Toledo AG | A multi-junction thermocouple sensor and a method for manufacturing the same |
US7077563B2 (en) * | 2003-11-19 | 2006-07-18 | General Electric Company | Deposition sensor based on differential heat flux measurement |
EP1689700A1 (en) * | 2003-11-25 | 2006-08-16 | Novo Nordisk A/S | Novel salicylic anilides |
EP1717566A1 (en) * | 2005-04-25 | 2006-11-02 | Mettler-Toledo AG | Thermoanalytical sensor |
US20070060620A1 (en) * | 2005-09-09 | 2007-03-15 | John Sefton | Use of RAR retinoid agonists to increase sperm count and sperm mobility in males |
DK1937244T3 (en) | 2005-09-30 | 2018-10-29 | Io Therapeutics Llc | : CANCER TREATMENT WITH SPECIFIC RXR AGONISTS |
GB0605683D0 (en) * | 2006-03-21 | 2006-05-03 | Servomex Group Ltd | Thermal conductivity sensor |
US20080273572A1 (en) * | 2006-06-02 | 2008-11-06 | James Madison University | Thermal detector for chemical or biological agents |
JP4849961B2 (en) * | 2006-06-05 | 2012-01-11 | エスアイアイ・ナノテクノロジー株式会社 | Thermal analyzer |
US7470057B2 (en) * | 2006-08-24 | 2008-12-30 | Waters Investments Limited | Differential scanning calorimeter sensor and method |
JP2008089474A (en) * | 2006-10-03 | 2008-04-17 | Rigaku Corp | Sensor unit for thermal analysis equipment and method for manufacturing the same |
FR2925163B1 (en) * | 2007-12-12 | 2010-02-26 | Centre Nat Rech Scient | METHOD AND APPARATUS FOR THERMAL ANALYSIS |
DE602008005427D1 (en) * | 2008-06-13 | 2011-04-21 | Mettler Toledo Ag | Heat analysis instrument with dynamic power compensation |
EP2214005B1 (en) * | 2009-02-03 | 2019-09-18 | Mettler-Toledo GmbH | Thermo-Analytical Instrument |
US8517600B2 (en) * | 2009-10-27 | 2013-08-27 | General Electric Company | Deposition sensor based on differential heat transfer resistance |
JP5642525B2 (en) * | 2010-02-02 | 2014-12-17 | 株式会社日立ハイテクサイエンス | Differential scanning calorimeter |
KR101853882B1 (en) * | 2011-01-10 | 2018-05-02 | 삼성전자주식회사 | Bio material test device and controlling method thereof |
WO2012125749A2 (en) * | 2011-03-14 | 2012-09-20 | Io Therapeutics, Inc. | INFLAMMATION AND AUTOIMMUNE DISORDER TREATMENT USING RARα SELECTIVE AGONISTS |
KR102055395B1 (en) | 2011-06-24 | 2019-12-12 | 쥐알아이 바이오,아이엔씨. | Prevention and treatment of inflammatory conditions |
US20140155381A1 (en) * | 2011-07-29 | 2014-06-05 | Erkan Baloglu | Compounds and methods |
US10653650B2 (en) | 2011-12-13 | 2020-05-19 | Io Therapeutics, Inc. | Treatment of diseases by concurrently eliciting remyelination effects and immunomodulatory effects using selective RXR agonists |
US20130190395A1 (en) | 2011-12-13 | 2013-07-25 | Dartmouth College | Autoimmune disorder treatment using rxr agonists |
WO2013185105A1 (en) | 2012-06-07 | 2013-12-12 | Children's Hospital Los Angeles | Methods for treating neutropenia using retinoid agonists |
JP2017508737A (en) | 2014-02-18 | 2017-03-30 | チルドレンズ ホスピタル ロサンゼルス | Compositions and methods for the treatment of neutropenia |
EP2921833B1 (en) * | 2014-03-18 | 2016-12-28 | Mettler-Toledo GmbH | Thermoanalytical sensor and method for its production |
US9463201B2 (en) | 2014-10-19 | 2016-10-11 | M.G. Therapeutics Ltd | Compositions and methods for the treatment of meibomian gland dysfunction |
AU2015360945B2 (en) | 2014-12-09 | 2021-07-29 | Gri Bio, Inc. | Prevention and treatment of inflammatory conditions |
US20160317654A1 (en) * | 2015-03-09 | 2016-11-03 | Kings College London | Combination therapy with rar alpha agonists for enhancing th1 response |
WO2016161107A1 (en) | 2015-03-31 | 2016-10-06 | Syros Pharmaceuticals, Inc. | METHODS OF STRATIFYING PATIENTS FOR TREATMENT WITH RETINOIC ACID RECEPTOR-α AGONISTS |
JP2018533622A (en) | 2015-09-28 | 2018-11-15 | アズーラ オフサルミックス エルティーディー. | Thiol and disulfide containing agents for increasing lipid secretion in the meibomian gland |
JP6823071B2 (en) | 2015-10-31 | 2021-01-27 | アイオー セラピューティクス インコーポレイテッド | Treatment of nervous system disorders with a combination of RXR agonists and thyroid hormones |
ES2898676T3 (en) * | 2015-11-25 | 2022-03-08 | Io Therapeutics Inc | Selective CYP26-resistant rar-alpha agonists in cancer treatment |
US10946001B2 (en) | 2016-03-10 | 2021-03-16 | Io Therapeutics, Inc. | Treatment of autoimmune diseases with combinations of RXR agonists and thyroid hormones |
KR20180121983A (en) | 2016-03-10 | 2018-11-09 | 아이오 테라퓨틱스, 인크. | Treatment of muscle disorders using a combination of RXR agonists and thyroid hormones |
US9868994B2 (en) | 2016-04-08 | 2018-01-16 | Syros Pharmaceuticals, Inc. | Methods of stratifying patients for treatment with retinoic acid receptor-α agonists |
CA3020173A1 (en) | 2016-04-08 | 2017-10-12 | Syros Pharmaceuticals, Inc. | Rara agonists for the treatment of aml and mds |
EP3442519A4 (en) | 2016-04-14 | 2019-12-04 | Azura Opthalmics Ltd. | Selenium disulfide compositions for use in treating meibomian gland dysfunction |
CN108078966B (en) * | 2016-11-22 | 2021-08-17 | 厦门大学 | Use of aromatic nitroethylene compounds |
JP2020526551A (en) | 2017-07-13 | 2020-08-31 | アイオー セラピューティクス インコーポレイテッド | Immunomodulatory retinoid and lexinoid compounds combined with immunomodulators for cancer immunotherapy |
CA3073953A1 (en) * | 2017-08-31 | 2019-03-07 | Io Therapeutics, Inc. | Rar selective agonists in combination with immune modulators for cancer immunotherapy |
AU2018335393A1 (en) | 2017-09-20 | 2020-04-02 | Io Therapeutics, Inc. | Treatment of disease with esters of selective RXR agonists |
US11474054B2 (en) * | 2018-10-22 | 2022-10-18 | Equistar Chemicals, Lp | Temperature control apparatuses and methods |
US10966950B2 (en) | 2019-06-11 | 2021-04-06 | Io Therapeutics, Inc. | Use of an RXR agonist in treating HER2+ cancers |
US20220259157A1 (en) * | 2019-06-28 | 2022-08-18 | Carl Wagner | Compositions Comprising a Retinoid X Receptor (RXR) Agonist, a Retinoic Acid Receptor (RAR) Agonist, or a Dual RXR/RAR Agonist |
CA3166357A1 (en) | 2020-01-10 | 2021-07-15 | Azura Ophthalmics Ltd. | Instructions for composition and sensitivity |
US11896558B2 (en) | 2021-12-07 | 2024-02-13 | Io Therapeutics, Inc. | Use of an RXR agonist and taxanes in treating Her2+ cancers |
US20230416190A1 (en) * | 2022-06-27 | 2023-12-28 | Io Therapeutics, Inc. | Synthesis of tetrahydronaphthalenols and uses thereof |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0170105A2 (en) * | 1984-07-07 | 1986-02-05 | Koichi Prof. Dr. Shudo | Benzoic acid derivatives |
EP0350846A2 (en) * | 1988-07-14 | 1990-01-17 | F. Hoffmann-La Roche Ag | Condensed heterocyclic compounds and their use in therapy |
EP0514269A1 (en) * | 1991-05-15 | 1992-11-19 | Centre International De Recherches Dermatologiques Galderma, ( Cird Galderma) | Imino-derivatives, process for their preparation and their use in human and veterinary medicine and in cosmetics |
WO1993003713A1 (en) * | 1991-08-23 | 1993-03-04 | The Salk Institute For Biological Studies | Use of selective ligands for treatment of disease states responsive to steroid or steroid-like hormones |
JPH0672866A (en) * | 1992-07-02 | 1994-03-15 | Chugoku Igakuka Gakuin Yakubutsu Kenkyusho | Differentiation inducing agent |
US5420145A (en) * | 1993-03-22 | 1995-05-30 | Koichi Shudo | Carboxylic acid derivative |
WO1996032101A1 (en) * | 1995-04-10 | 1996-10-17 | Taiho Pharmaceutical Co., Ltd. | Cancerous metastasis inhibitor |
Family Cites Families (88)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4067975A (en) * | 1975-08-04 | 1978-01-10 | Yu Ruey J | Treatment of psoriasis with 6-aminonicotinamide and thionicotinamide |
US4085091A (en) | 1976-12-16 | 1978-04-18 | E. I. Dupont De Nemours And Company | Thermally stable, rigid polyesters from thermally stable, rigid dibasic acids and aromatic dihydroxy compounds |
US4111717A (en) * | 1977-06-29 | 1978-09-05 | Leeds & Northrup Company | Small-size high-performance radiation thermopile |
US4326055A (en) | 1977-12-22 | 1982-04-20 | Hoffmann-La Roche Inc. | Stilbene derivatives |
FR2440353A1 (en) * | 1978-11-03 | 1980-05-30 | Science Union & Cie | NOVEL ARYLETHANOLS, PROCESSES FOR OBTAINING THEM AND THEIR USE AS A MEDICINAL PRODUCT |
EP0047817A3 (en) | 1980-08-14 | 1982-05-26 | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft | Hydrogenated naphthalines, their preparation and application, and mixtures containing such naphthalines |
CH651034A5 (en) | 1982-05-12 | 1985-08-30 | Hoffmann La Roche | CHROMAN, THIOCHROMAN OR 1,2,3,4-TETRAHYDROCHINOLIN DERIVATIVES AND THEIR USE AS MEDICINAL ACTIVE SUBSTANCES. |
DK158947C (en) | 1982-07-06 | 1991-01-21 | Hoffmann La Roche | TETRAHYDRONAPHTHALIN, BENZOFURAN AND BENZOTHIOPHENDER DERIVATIVES, PREPARATION AND USE THEREOF, AND RODENTICID CONTAINING SUCH DERIVATIVES |
US4794188A (en) * | 1982-12-01 | 1988-12-27 | Usv Pharmaceutical Corporation | Certain unsymmetrical quinolinyl ethers having anti-inflammatory and anti-allergic activity |
ATE38835T1 (en) | 1983-07-05 | 1988-12-15 | Pfizer | CARBONIC ACID DERIVATIVES USEFUL IN PREVENTING DECOMPOSITION OF CARTILAGE. |
WO1985000806A1 (en) | 1983-08-08 | 1985-02-28 | Sri International | Benzonorbornenyl, benzopyranyl and benzothiopyranyl retinoic acid analogues |
FR2562539B1 (en) | 1984-04-06 | 1987-04-17 | Chauvin Blache Lab | NOVEL VINYL-4 BENZOIC ACID DERIVATIVES, PREPARATION METHOD THEREOF AND THERAPEUTIC APPLICATIONS THEREOF AND AS LIGANDS |
US4826984A (en) | 1984-04-09 | 1989-05-02 | The Board Of Regents For The Oklahoma Agricultural And Mechanical College Acting For And On Behalf Of Oklahoma State University | Heteroarotinoid compounds as anticancer agents |
JPS60222445A (en) | 1984-04-19 | 1985-11-07 | Yoshitomi Pharmaceut Ind Ltd | Phthalic acid compound |
JPS6122046A (en) | 1984-07-07 | 1986-01-30 | Koichi Shiyudo | Stilbene derivative |
LU85544A1 (en) | 1984-09-19 | 1986-04-03 | Cird | AROMATIC HETEROCYCLIC DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION IN THE THERAPEUTIC AND COSMETIC FIELDS |
DE3434947A1 (en) | 1984-09-22 | 1986-04-03 | Basf Ag, 6700 Ludwigshafen | ISOXAZOLIC CARBONIC ACID DERIVATIVES, THEIR PRODUCTION AND USE |
DE3434942A1 (en) | 1984-09-22 | 1986-04-03 | Basf Ag, 6700 Ludwigshafen | TETRALINE DERIVATIVES, THEIR PRODUCTION AND USE |
DE3434946A1 (en) | 1984-09-22 | 1986-04-03 | Basf Ag, 6700 Ludwigshafen | DIARYLACETYLENE, THEIR PRODUCTION AND USE |
HU194405B (en) * | 1985-05-10 | 1988-01-28 | Magyar Optikai Muevek | Temperature control system for testing thermic phase transformations |
DE3529489A1 (en) * | 1985-08-16 | 1987-02-26 | Max Planck Gesellschaft | METHOD AND DEVICE FOR DETERMINING THE HEAT CAPACITY OF A SAMPLE |
IL80270A0 (en) | 1985-10-11 | 1987-01-30 | Cird | Naphthalene derivatives,their preparation and pharmaceutical compositions containing them |
DE3602473A1 (en) | 1986-01-28 | 1987-07-30 | Basf Ag | VINYLPHENOL DERIVATIVES, THEIR PRODUCTION AND USE |
LU86351A1 (en) | 1986-03-12 | 1987-11-11 | Oreal | BENZOPYRANNYL AND BENZOTHIOPYRANNYL BENZOIC COMPOUNDS, PROCESS FOR THEIR PREPARATION AND THEIR USE IN COSMETICS AND HUMAN AND VETERINARY MEDICINE |
DE3615157A1 (en) | 1986-05-05 | 1987-11-12 | Schwabe Willmar Gmbh & Co | 5-ARYLALKYL-4-ALKOXY-2 (5H) -FURANONE, INTERMEDIATE PRODUCTS AND METHOD FOR THE PRODUCTION THEREOF AND THEIR USE AS THERAPEUTIC ACTIVE SUBSTANCES |
ZW6587A1 (en) | 1986-05-13 | 1987-12-02 | Hoffmann La Roche | Tetrahydro naphthanline derivatives |
ZW7487A1 (en) | 1986-05-23 | 1987-12-16 | Hoffmann La Roche | Tetrahydronaphthaline and indane derivatives |
ZW10287A1 (en) | 1986-07-15 | 1988-01-13 | Hoffmann La Roche | Tetrahydronaphthaline and indane derivatives |
US4739098A (en) | 1986-09-22 | 1988-04-19 | Allergan, Inc. | Ethynylphenyl-containing retinoic acid derivatives |
NZ222968A (en) | 1986-12-24 | 1990-05-28 | Allergan Inc | Ethynylheteroaromatic derivatives and medicaments |
US4927947A (en) | 1986-12-24 | 1990-05-22 | Allergan, Inc. | Ethynylheteroaromatic-acids having retinoic acid-like activity |
US5264578A (en) | 1987-03-20 | 1993-11-23 | Allergan, Inc. | Disubstituted acetylenes bearing heterobicyclic groups and heteroaromatic or phenyl groups having retinoid like activity |
US5234926A (en) | 1987-03-20 | 1993-08-10 | Allergan, Inc. | Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity |
CA1305480C (en) | 1987-03-20 | 1992-07-21 | Roshantha A.S. Chandraratna | Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity |
US5089509A (en) | 1988-09-15 | 1992-02-18 | Allergan, Inc. | Disubstituted acetylenes bearing heteroaromatic and heterobicyclic groups having retinoid like activity |
US4810804A (en) | 1987-03-26 | 1989-03-07 | Allergan, Inc. | Acetylenes disubstituted with a phenyl group and a heterobicyclic group having retinoid-like activity |
ZA885192B (en) | 1987-08-19 | 1989-04-26 | Hoffmann La Roche | Pharmaceutical preparations |
CA1298309C (en) | 1987-11-06 | 1992-03-31 | Michael Klaus | Benzocycloheptene derivatives |
US5231113A (en) | 1988-04-11 | 1993-07-27 | Allergan, Inc. | Tetralin esters of phenols or benzoic acids having retinoid like activity |
KR0139216B1 (en) | 1988-04-11 | 1998-05-01 | 제임스 엠. 캐내지 | Tetralin esters of phenols or benzoic acids having retinoic like activity |
US4895868A (en) | 1988-06-29 | 1990-01-23 | Allergan, Inc. | Thiochroman esters of phenols and terephthallates having retinoid-like activity |
US5015658A (en) | 1988-06-29 | 1991-05-14 | Allergan, Inc. | Thiochroman esters of phenols and terephthallates having retinoid-like activity |
US4992468A (en) | 1989-07-26 | 1991-02-12 | Allergan, Inc. | Phenylethenyl compounds having retinoid-like activity |
US5068252A (en) | 1989-07-26 | 1991-11-26 | Allergan, Inc. | Methods of using phenylethenyl compounds having retinoid-like activity |
US5399561A (en) | 1989-09-19 | 1995-03-21 | Allergan, Inc. | Acetylenes disubstituted with a phenyl or heteroaryl group and a 2-oxochromanyl, 2-oxothiochromanyl or 2-oxo-1,2,3,4-tetrahydro-quinolinyl group having retinoid-like biological activity |
US5053523A (en) | 1989-09-19 | 1991-10-01 | Allergan, Inc. | Ethynyl-chroman compounds |
US5162546A (en) | 1989-09-19 | 1992-11-10 | Allergan, Inc. | Acetylenes disubstituted with a phenyl group and a 2-substituted chromanyl, thiochromanyl or 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity |
US5045551A (en) | 1989-09-19 | 1991-09-03 | Allergan, Inc. | Acetylenes disubstituted with a heteroaromatic group and a 2-substituted chromanyl, thiochromanyl or 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity |
US5023341A (en) | 1989-09-19 | 1991-06-11 | Allergan, Inc. | Compounds having a disubstituted acetylene moiety and retinoic acid-like biological activity |
US5183827A (en) | 1989-09-19 | 1993-02-02 | Allergan, Inc. | Acetylenes disubstituted with a heteroaromatic group and a 2-substituted chromanyl, thiochromanyl or 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity |
US5272156A (en) | 1989-09-19 | 1993-12-21 | Allergan, Inc. | Acetylenes disubstituted with a heteroaromatic group and a 2-substituted 1,2,3,4-tetrahydroquinolinyl group having retinoid-like activity |
US5248777A (en) | 1989-09-19 | 1993-09-28 | Allergan, Inc. | Process and intermediates for preparing compounds having a disubstituted acetylene moiety and retinoic acid-like biological activity |
US4980369A (en) | 1989-09-19 | 1990-12-25 | Allergan, Inc. | Acetylenes disubstituted with a phenyl group and a 2-substituted chromanyl or thiochromanyl group having retinoid-like activity |
US5006550A (en) | 1989-12-29 | 1991-04-09 | Allergan, Inc. | Chroman esters of phenols and benzoic acids having retinoid-like activity |
US5175185A (en) | 1989-12-29 | 1992-12-29 | Allergan, Inc. | Acetylenes disubstituted with a heteroaromatic group and a substituted phenyl group having retinoid like activity |
US5264456A (en) | 1989-12-29 | 1993-11-23 | Allergan, Inc. | Acetylenes disubstituted with a furyl group and a substituted phenyl group having retinoid like activity |
US5013744B1 (en) | 1989-12-29 | 1994-09-20 | Allegran Inc | Acetylenes disubstituted with a pyridinyl group and a substituted phenyl group having retinoid like activity |
US5202471A (en) | 1990-02-06 | 1993-04-13 | Allergan, Inc. | Alkyl, alkoxy and thioalkoxy substituted diphenyl acetylenes having retinoid like activity |
CA2080581A1 (en) | 1990-04-16 | 1991-10-17 | Alfred P. Spada | Styryl-substituted monocyclic and bicyclic heteroaryl compounds which inhibit egf receptor tyrosine kinase |
LU87821A1 (en) | 1990-10-12 | 1992-05-25 | Cird Galderma | BI-AROMATIC COMPOUNDS, AND THEIR USE IN HUMAN AND VETERINARY MEDICINE AND IN COSMETICS |
EP0571546B1 (en) | 1991-02-13 | 1996-10-16 | Allergan, Inc. | Chroman and thiochromans with phenylethynyl substituents at the 7-position having retinoid-like biological activity |
US5134159A (en) | 1991-03-26 | 1992-07-28 | Allergan, Inc. | 7-chromanyl esters of phenols and benzoic acids having retinoid-like activity |
JP3157523B2 (en) | 1991-03-26 | 2001-04-16 | アラーガン、インコーポレイテッド | Chromans and thiochromans having a heteroarylethynyl substituent at position 7 with retinoid-like biological activity |
CA2129831A1 (en) | 1992-02-11 | 1993-08-19 | Roshantha A. S. Chandraratna | Heteroaryl substituted phenylethenyl compounds having retinoid-like biological activity |
US5326898A (en) | 1992-02-11 | 1994-07-05 | Allergan, Inc. | Substituted phenylethenyl compounds having retinoid-like biological activity |
US5324840A (en) | 1992-06-11 | 1994-06-28 | Allergan, Inc. | Method of treatment with compounds having retinoid-like activity and reduced skin toxicity and lacking teratogenic effects |
US5288147A (en) * | 1992-11-09 | 1994-02-22 | Ta Instruments, Inc. | Thermopile differential thermal analysis sensor |
US5455265A (en) | 1993-02-11 | 1995-10-03 | Allergan, Inc. | Method of treatment with compounds having selective agonist-like activity on RXR retinoid receptors |
US5399586A (en) | 1993-03-11 | 1995-03-21 | Allergan, Inc. | Treatment of mammals afflicted with tumors with compounds having RXR retinoid receptor agonist activity |
EP0619116A3 (en) * | 1993-04-05 | 1994-11-23 | Hoechst Japan | Use of synthetic retinoids for osteopathy. |
US5344959A (en) | 1993-05-18 | 1994-09-06 | Allergan, Inc. | Tetrahydronaphthyl and cyclopropyl substituted 1,3-butadienes having retinoid-like activity |
US5475022A (en) | 1993-10-18 | 1995-12-12 | Allergan, Inc. | Phenyl or heteroaryl and tetrahydronaphthyl substituted diene compounds having retinoid like biological activity |
US5668174A (en) * | 1993-12-29 | 1997-09-16 | Kowa Tekuno Sachi Co., Ltd. | Method of treating hyperparathyroidism |
US5451605A (en) | 1993-12-30 | 1995-09-19 | Allergan, Inc. | 1,2-epoxycyclohexanyl and bicyclic aromatic substituted ethyne compounds having retinoid-like biological activity |
US5470999A (en) | 1993-12-30 | 1995-11-28 | Allergan, Inc. | Cyclohexene and bicyclic aromatic substituted ethyne compounds having retinoid-like biological activity |
US5426118A (en) | 1993-12-30 | 1995-06-20 | Allergan, Inc. | [4-(1,2-epoxycyclohexanyl)but-3-en-1-ynyl]aromatic and heteroaromatic acids and derivatives having retinoid-like biological activity |
CA2138000A1 (en) | 1994-01-03 | 1995-07-04 | John E. Starrett, Jr. | Retinoid-like compounds |
US5498755A (en) | 1994-08-23 | 1996-03-12 | Chandraratna; Roshantha A. | Disubstituted aryl and heteroaryl imines having retinoid-like biological activity |
US5498795A (en) | 1994-12-29 | 1996-03-12 | Allergan, Inc. | Acetylenes disubstituted with hydroxyaryl and aryl or heteroaryl groups having retinoid-like biological activity |
US5489584A (en) | 1994-12-29 | 1996-02-06 | Allergan, Inc. | Acetylenes disubstituted with a 5-amino or substituted 5-amino substituted tetrahydronaphthyl group and with an aryl or heteroaryl group having retinoid-like biological activity |
FR2733564B1 (en) * | 1995-04-27 | 1997-06-20 | Peugeot | DAMPING ARRANGEMENT BY ROLLING A FLUID AND SUSPENSION SYSTEM, ESPECIALLY A MOTOR VEHICLE, EQUIPPED WITH SUCH A DAMPING ARRANGEMENT |
US5779363A (en) * | 1995-09-27 | 1998-07-14 | The Johns Hopkins University | Capillary calorimetric cell and method of manufacturing same |
US5965606A (en) * | 1995-12-29 | 1999-10-12 | Allergan Sales, Inc. | Methods of treatment with compounds having RAR.sub.α receptor specific or selective activity |
US5813763A (en) * | 1996-10-11 | 1998-09-29 | Microcal Incorporated | Ultrasensitive differential microcalorimeter |
WO1998020314A2 (en) * | 1996-11-01 | 1998-05-14 | Ta Instruments, Inc. | Differential scanning calorimeter |
US6079873A (en) * | 1997-10-20 | 2000-06-27 | The United States Of America As Represented By The Secretary Of Commerce | Micron-scale differential scanning calorimeter on a chip |
JPH11160226A (en) * | 1997-12-01 | 1999-06-18 | Mitsubishi Chemical Corp | Manufacturing method for corrosion sensor |
JP3137605B2 (en) * | 1998-07-14 | 2001-02-26 | セイコーインスツルメンツ株式会社 | Heat flux type differential scanning calorimeter |
-
1995
- 1995-12-29 US US08/580,553 patent/US5965606A/en not_active Expired - Fee Related
-
1996
- 1996-12-16 EP EP96944978A patent/EP0869782A2/en not_active Withdrawn
- 1996-12-16 JP JP09524502A patent/JP2000502707A/en not_active Ceased
- 1996-12-16 RU RU98114840/14A patent/RU2191009C2/en not_active IP Right Cessation
- 1996-12-16 CZ CZ982069A patent/CZ206998A3/en unknown
- 1996-12-16 IL IL12512196A patent/IL125121A0/en unknown
- 1996-12-16 CA CA002241758A patent/CA2241758A1/en not_active Abandoned
- 1996-12-16 CN CN96180109A patent/CN1211180A/en active Pending
- 1996-12-16 KR KR1019980704939A patent/KR19990076814A/en not_active Application Discontinuation
- 1996-12-16 PL PL96327627A patent/PL327627A1/en unknown
- 1996-12-16 AU AU13450/97A patent/AU710483B2/en not_active Ceased
- 1996-12-16 HU HU0001643A patent/HUP0001643A3/en unknown
- 1996-12-16 NZ NZ326155A patent/NZ326155A/en unknown
- 1996-12-16 WO PCT/US1996/020511 patent/WO1997024116A2/en not_active Application Discontinuation
- 1996-12-16 BR BR9612318-4A patent/BR9612318A/en not_active IP Right Cessation
-
1998
- 1998-06-29 MX MX9805282A patent/MX9805282A/en not_active IP Right Cessation
-
1999
- 1999-07-09 US US09/350,310 patent/US6534544B1/en not_active Expired - Fee Related
-
2001
- 2001-11-29 US US09/998,358 patent/US6610744B2/en not_active Expired - Fee Related
- 2001-11-30 US US09/998,356 patent/US6508585B2/en not_active Expired - Fee Related
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0170105A2 (en) * | 1984-07-07 | 1986-02-05 | Koichi Prof. Dr. Shudo | Benzoic acid derivatives |
EP0350846A2 (en) * | 1988-07-14 | 1990-01-17 | F. Hoffmann-La Roche Ag | Condensed heterocyclic compounds and their use in therapy |
EP0514269A1 (en) * | 1991-05-15 | 1992-11-19 | Centre International De Recherches Dermatologiques Galderma, ( Cird Galderma) | Imino-derivatives, process for their preparation and their use in human and veterinary medicine and in cosmetics |
WO1993003713A1 (en) * | 1991-08-23 | 1993-03-04 | The Salk Institute For Biological Studies | Use of selective ligands for treatment of disease states responsive to steroid or steroid-like hormones |
JPH0672866A (en) * | 1992-07-02 | 1994-03-15 | Chugoku Igakuka Gakuin Yakubutsu Kenkyusho | Differentiation inducing agent |
US5420145A (en) * | 1993-03-22 | 1995-05-30 | Koichi Shudo | Carboxylic acid derivative |
WO1996032101A1 (en) * | 1995-04-10 | 1996-10-17 | Taiho Pharmaceutical Co., Ltd. | Cancerous metastasis inhibitor |
Non-Patent Citations (5)
Title |
---|
CHEMICAL ABSTRACTS, vol. 121, no. 9, 1994, Columbus, Ohio, US; abstract no. 108128d, XP002030814 * |
DATABASE WPI Section Ch Week 9416, Derwent World Patents Index; Class B05, AN 94-128759, XP002030803 * |
KAGECHIKA H ET AL: "RETINOBENZOIC ACIDS STRUCTURE-ACTIVITY RELATIONSHIPS OF AROMATIC AMIDES WITH RETINOIDAL ACTIVITY", JOURNAL OF MEDICINAL CHEMISTRY, vol. 31, no. 11, November 1988 (1988-11-01), pages 2182 - 2192, XP000608417 * |
MIN TENG ET AL: "Identification of a Retinoic Acid Receptor alpha Subtype Specific Agonist", J. MED. CHEM., vol. 39, no. 16, 2 August 1996 (1996-08-02), pages 3035 - 3038, XP000652115 * |
YU, BAOXIN ET AL: "Synthesis of p-substituted benzoylaminobenzoic acid (methyl esters) and its differentiation induction activities of human promyelocytic leukemia cells HL-60", HUAXI YIKE DAXUE XUEBAO, vol. 25, no. 1, 1994, pages 30 - 34 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8198329B2 (en) | 2004-03-10 | 2012-06-12 | Research Foundation Itsuu Laboratory | Memory consolidation promoting agent and method of use |
US8431613B2 (en) | 2004-03-10 | 2013-04-30 | Research Foundation Itsuu Laboratory | Memory fixation accelerator |
Also Published As
Publication number | Publication date |
---|---|
RU2191009C2 (en) | 2002-10-20 |
US5965606A (en) | 1999-10-12 |
CN1211180A (en) | 1999-03-17 |
HUP0001643A2 (en) | 2001-05-28 |
AU710483B2 (en) | 1999-09-23 |
CA2241758A1 (en) | 1997-07-10 |
US6610744B2 (en) | 2003-08-26 |
AU1345097A (en) | 1997-07-28 |
WO1997024116A2 (en) | 1997-07-10 |
US20020085615A1 (en) | 2002-07-04 |
KR19990076814A (en) | 1999-10-15 |
JP2000502707A (en) | 2000-03-07 |
BR9612318A (en) | 1999-12-28 |
CZ206998A3 (en) | 1999-04-14 |
US20020077360A1 (en) | 2002-06-20 |
IL125121A0 (en) | 1999-01-26 |
US6508585B2 (en) | 2003-01-21 |
US6534544B1 (en) | 2003-03-18 |
HUP0001643A3 (en) | 2003-01-28 |
EP0869782A2 (en) | 1998-10-14 |
PL327627A1 (en) | 1998-12-21 |
NZ326155A (en) | 2000-08-25 |
MX9805282A (en) | 1998-10-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO1997024116A3 (en) | METHODS OF TREATMENT WITH COMPOUNDS HAVING RARα RECEPTOR SPECIFIC OR SELECTIVE ACTIVITY | |
NO2005009I2 (en) | Emselex-darifenacin. Iupac name: (S) -2-α1-α2- (2,3-dihydrobenzofuran-5-yl) ethylÜ-3-pyrrolidinylü-2,2-diphenylacetamide | |
ZA969992B (en) | Mono-olefin/polyene interpolymers, method of preparation, compositions containing the same, and articles made thereof. | |
AU1208197A (en) | Novel n-(substituted or unsubstituted)-4-substituted-6- (substituted or unsubstituted) phenoxy-2-pyridine carboxamide or thiocarboxamide, process for producing the same and herbicide using the same | |
BR9610838A (en) | Process for treating an individual having a pathological condition involving neovascularization. | |
NO965084D0 (en) | N- [3- (3-cyanopyrazolo [1,5-aÅpyrimidin-7-yl) fenylÅ -N-ethyl-acetamide | |
IT1283325B1 (en) | PACKAGING FOR SINGLE PACKAGES, AS WELL AS PROCEDURE AND DEVICE TO PRODUCE IT | |
ZA966579B (en) | O/W emulsion composition for eye drops. | |
IT1280812B1 (en) | MAGNETOTHERAPY APPARATUS. | |
MX9600754A (en) | An animal ear tag and method of application. | |
AU1894295A (en) | 2-cyano-1,3-dione derivatives useful as herbicides | |
PT751764E (en) | RETINAL COMPOSITION | |
ES1023162Y (en) | TREATMENT APPARATUS, IN PARTICULAR FOR FACIAL COSMETIC TREATMENT. | |
ES1030858Y (en) | PLANTING MACHINE FOR VEGETABLES AND SIMILAR. | |
BR9915460A (en) | Method of treatment of viral hemorrhagic fever | |
ZA964198B (en) | Treatment regime for skin. | |
EP1018336A4 (en) | Carcinostatics | |
BR9606955A (en) | Substituted heterocycloalkenes | |
ATE320263T1 (en) | USE OF HUMAN PROTEIN C FOR PRODUCING A MEDICINAL PRODUCT FOR TREATING HEPARIN-INDUCED THROMBOCYTOPENIA | |
FR2748919B1 (en) | ADJUSTABLE ARMCHAIR, PARTICULARLY FOR GIVING BOTTLE | |
PL343079A1 (en) | Biotin-binding receptor molecules | |
AU7227296A (en) | 2-cyano-1,3-dione derivatives and herbicides containing the same as active ingredient | |
MA21945A1 (en) | PROCESS FOR OBTAINING AN EXTRACELLULAR EXOPOLYMER, EXOPOLYMER THUS OBTAINED AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME. | |
UA42749C2 (en) | Dimaleate salt of n, n-diethyl-8, 8-dipropyl-2-azaspiro[4.5] decane-2-propanamine, pharmaceutical composition, treatment method | |
ES1024176Y (en) | PERFECTED APPARATUS FOR SKIN TREATMENT FOR AESTHETIC PURPOSES. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 96180109.3 Country of ref document: CN |
|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG UZ VN AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
AK | Designated states |
Kind code of ref document: A3 Designated state(s): AL AM AT AU AZ BA BB BG BR BY CA CH CN CU CZ DE DK EE ES FI GB GE HU IL IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MD MG MK MN MW MX NO NZ PL PT RO RU SD SE SG SI SK TJ TM TR TT UA UG UZ VN AM AZ BY KG KZ MD RU TJ TM |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): KE LS MW SD SZ UG AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI |
|
ENP | Entry into the national phase |
Ref document number: 2241758 Country of ref document: CA Ref document number: 2241758 Country of ref document: CA Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1019980704939 Country of ref document: KR |
|
WWE | Wipo information: entry into national phase |
Ref document number: PV1998-2069 Country of ref document: CZ Ref document number: 98-01121 Country of ref document: RO Ref document number: PA/A/1998/005282 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 326155 Country of ref document: NZ |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1996944978 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 1996944978 Country of ref document: EP |
|
REG | Reference to national code |
Ref country code: DE Ref legal event code: 8642 |
|
WWP | Wipo information: published in national office |
Ref document number: PV1998-2069 Country of ref document: CZ |
|
WWP | Wipo information: published in national office |
Ref document number: 1019980704939 Country of ref document: KR |
|
WWR | Wipo information: refused in national office |
Ref document number: 1019980704939 Country of ref document: KR |
|
WWR | Wipo information: refused in national office |
Ref document number: PV1998-2069 Country of ref document: CZ |